Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Pharma Talk Radio



Follow This Show

Stay in the know about new episodes and updates.
PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.

On-Demand Episodes

Director, Valerie Bowling, reviews what to expect at the upcoming Clinical Research as a Care Option (CRAACO) conference taking place on May 22-23 at the Sheraton Imperial Hotel in Raleigh-Durham, NC.

In this podcast, you will hear a panel discussion moderated by Paul Jansen from the 2022 PODD Conference regarding the biggest challenges as well as future solutions to vaccine administration and distribution. Panelists include: Jeffrey T... more

In this podcast, you will hear a panel discussion moderated by Mark DeStefano, Teva, from the 2022 PODD Conference regarding balancing the level of connected activity with user needs, determining how broadly or specifically to... more

Why is enhancing the interferon pathway an attractive approach for treating cancer? What are the novel therapeutic approaches being investigated to harness the innate immune system to enhance the interferon pathway to treat cancer?... more

In this talk, first recorded at the 2022 IO360° Summit, Dr Rachel Haurwitz, CEO, Caribou Biosciences, addresses the big picture view of where the cell therapy field is going and how innovative CRISPR-based editing will help with... more

Moderated by: Axel Hoos, MD, PhD, CEO, Scorpion Therapeutics Panelists: Jonathan Fassberg, Vice Chairman of Healthcare Investment Banking, Oppenheimer Irina Margine, PhD, Principal, Biotech Private Equity, Wellington... more

This panel, first recorded at the 2022 IO360° Summit addressed: What are the risks and implications of investing in cell/gene therapy companies who have no clinical data from programs available? Venture company perspectives... more

In this session, first recorded at the 2022 IO360° Summit, Dr Semenza will talk about how his work is impacting cancer immunotherapy. Dr Semenza's groundbreaking discovery of hypoxia-inducible factors paves the way for the... more

Neoadjuvant (pre-surgical) immune checkpoint blockade may prevent cancer relapse and progression. This treatment approach is now FDA-approved for resectable triple-negative breast cancer, and hundreds of clinical trials in other... more

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled